Journals / Pamukkale Tıp Dergisi / 2020 / Cilt: 13 - Sayı: 1

A rare genetic ataxia: cerebrotendinous xanthomatozis.

Nadir görülen bir genetik ataksi: serebtotendinoz ksantomatozis.

Pages
225–228
Publication Date
2020-01-21
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case we shared the rehabilitation process of our patient with CTX.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cerebrotendinous xanthomatosis (CTX) is a rare and treatable lipid storage disease.
📊
Key Findings & Data:Clinical findings include persistent infantil diarrhea, cataracts in adolescent, tendon xanthomas and neurologic disorders such as ataxia, seizures, personality changes in adulthood. 37 years old woman, diagnosed CTX 6 years ago, complained of balance loss and walking difficulty.
💡
Conclusion & Impact:In this case we shared the rehabilitation process of our patient with CTX.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ataksi · Düşük ayak · Rehabilitasyon

Abstract

Cerebrotendinous xanthomatosis (CTX) is a rare and treatable lipid storage disease. It is one of the causes of adult onset ataxia. Clinical findings include persistent infantil diarrhea, cataracts in adolescent, tendon xanthomas and neurologic disorders such as ataxia, seizures, personality changes in adulthood. 37 years old woman, diagnosed CTX 6 years ago, complained of balance loss and walking difficulty. Bilateral lower extremities were assessed with manual muscle testing and muscles strength were 4/5. She had bilateral lower extremity achilles clonus. Drop foot was observed when walking. We planned a rehabilitation program for balance and walking ability. Bilateral lower extremities strengthening program was performed. Foot-up ortheses were suggested for drop foot. Lower extremity clonus was stopped with baclofen 30 mg/day oral medication. Most of patients are diagnosed after the symptoms had started. It is believed the progression was stopped by the therapy. Personalized rehabilitation programs can improve functions and quality of life of this patients. In this case we shared the rehabilitation process of our patient with CTX.

Özet

Serebrotendinoz ksantomatozis (CTX) nadir görülen ve tedavi edilebilir bir lipid depo hastalığıdır. Erişkin başlangıçlı ataksi nedenlerinden biridir. Klinik bulgular infantil dönemde inatçı diyare, adolesan dönemde katarakt ve erişkin dönemde tendon ksantomları ve ataksi, epilepsi, kişilik değişikliği gibi nörolojik bozukluklar ile seyretmektedir. 6 yıl önce CTX tanısı alan, 37 yaşında kadın hasta kliniğimize denge bozukluğu ve yürümede güçlük şikayetiyle başvurdu. Her iki alt ekstremite kas kuvvetleri 4/5’ti ve bilateral aşil klonusu mevcuttu. Ambulasyon sırasında bilateral düşük ayak yürüyüşü dikkati çekiyordu. Hasta denge rehabilitasyonu ve yürüme eğitimi programına alındı. Her iki alt ekstremiteye kuvvetlendirme egzersizleri uygulandı. Foot-up yürüyüş ortezi ile düşük ayak yürüyüşü kontrol altına alındı. Baklofen tedavisi ile klonus giderildi. CTX hastaları, çoğunlukla nörolojik bozukluklar başladıktan sonra tanı alır ve tedavi ile hastalık progresyonu önlenmeye çalışılır. Bu hastalarda kişiye özel oluşturulmuş rehabilitasyon programlarıyla semptomların yaşam kalitesine olan etkisi azaltılabilir. Biz de bu olgumuzda CTX nedeniyle ataksi ve yürüme güçlüğü olan hastamızın rehabilitasyon sürecini paylaşacağız.

🔖

Cite This Article

ZİNCİRCİ, D. E., ÖNDER, B., KESİKTAŞ, F. N. (2020). A rare genetic ataxia: cerebrotendinous xanthomatozis.. Pamukkale Tıp Dergisi, Cilt: 13 - Sayı: 1, 225–228. https://ajindex.com/articles/696497

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Referans1 Daroff RB, Jankovic J, Mazziotta JC, Pomeroy SL. Bradley's neurology in clinical practice. 7th ed. Elsevier, 2016
  2. Referans2 Aminoff MJ, Josephson SA. Aminoff's neurology and general medicine, 5th ed. Elsevier, 2014
  3. Referans3 Karakaplan M, Ergen E, Görmeli G, Korkmaz MF, Elmalı N. Bilateral achilles tendon xanthomas in a patient with cerebrotendinous xanthomatosis a case report. J Am Podiatr Med Assoc 2017
  4. https://doi.org/10.7547/15-085 Referans4 Nie S, Chen G, Cao X, Zhang Y. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis 2014
  5. https://doi.org/10.1186/s13023-014-0179-4 Referans5 Degos B et al. Natural history of cerebrotendinous xanthomatosis: A paediatric disease diagnosed in adulthood. Orphanet Journal of Rare Diseases 2016
  6. https://doi.org/10.1186/s13023-016-0419-x Referans6 Berginer VM, Salen G, Shefer S. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. New England Journal of Medicine 1984
  7. https://www.nejm.org/doi/10.1056/NEJM198412273112601 Referans7 Bonnot O et al. Cerebrotendinous xanthomatosis presenting with severe externalized disorder: Improvement after one year of treatment with chenodeoxycholic acid. CNS Spectrums 2010
  8. 231–236. https://doi.org/10.1002/ajmg.a.38314 Referans8 Gill-Body KM, Popat RA, Parker SW, Krebs DE. Rehabilitation of balance in two patients with cerebellar dysfunction. Phys Ther 1997
  9. Referans9 Federico A, Dotti MT, Lore F, Nuti R. Cerebrotendinous xanthomatosis: pathophysiological study on bone metabolism. J Neurol Sci 1993
  10. 67–70. https://doi.org/10.1016/0022-510X(93)90068-A Referans10 Kuriyama M, Fujiyama J, Kubota R, Nakagawa M, Osame M. Osteoporosis and increased bone fractures in cerebrotendinous xanthomatosis. Metabolism 1993
  11. 1497–1498. https://doi.org/10.1016/0026-0495(93)90174-M